Status:
UNKNOWN
Clinical and Molecular Staging of Lung Cancer Stages I and IIp
Lead Sponsor:
Corporacion Parc Tauli
Collaborating Sponsors:
Instituto de Salud Carlos III
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Conditions:
Lung Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
The classification of lung cancer (LC) according to the degree of anatomical extension (TNM) allows the estimation of the prognosis of the patient, although its accuracy is limited. In fact, one third...
Eligibility Criteria
Inclusion
- over 18 years old
- Able to understand and sign the informed consent
Exclusion
- Absence of mediastinal disease
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03286036
Start Date
January 1 2013
End Date
December 31 2020
Last Update
February 15 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Son Espases
Palma de Mallorca, Balearic Islands, Spain, 07010
2
Hospital Germans Trias i Pujol
Badalona, Barcelona, Spain, 08916
3
Hospital del Mar
Barcelona, Spain, 08003
4
Hospital Virgen del Rocio
Seville, Spain, 41013